A 5′-flanking region polymorphism in toll-like receptor 4 is associated with gastric cancer in a Chinese population

Journal of Biomedical Research

Volumn 24, Issue 2, 2010, Pages 100-106

  Huang, Hua ^a   Wu, Juan ^a   Jin, Guangfu ^a   Zhang, Hanze ^a   Ding, Yanbing ^b   Hua, Zhaolai ^c   Zhou, Yan ^d   Xue, Yan ^b   Lu, Yan ^a   Hu, Zhibin ^a   Xu, Yaochu ^a   Shen, Hongbing ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Affiliated Hospital of Yangzhou University   (China)

^c Yangzhong Cancer Research Institute   (China)

^d YIXING PEOPLE S HOSPITAL   (China)

Author keywords

gastric cancer; polymorphisms; susceptibility; toll like receptor 4

Indexed keywords

CYTOSINE; THYMINE; TOLL LIKE RECEPTOR 4;

5' UNTRANSLATED REGION; ADULT; ALLELE; ARTICLE; CANCER CONTROL; CANCER INCIDENCE; CANCER SUSCEPTIBILITY; CHINESE; DNA FLANKING REGION; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HELICOBACTER INFECTION; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEIC ACID BASE SUBSTITUTION; POPULATION BASED CASE CONTROL STUDY; POPULATION GENETICS; PRIORITY JOURNAL; STOMACH CANCER; STOMACH CARCINOGENESIS; WILD TYPE;

EID: 77951251187     PISSN: 16748301     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1674-8301(10)60017-6     Document Type: Article

References (26)

1. Farinha P., and Gascoyne R.D. Molecular pathogenesis of mucosa-associated lymphoid tissue lymphoma. J Clin Oncol 23 (2005) 6370-6378
2. Smith Jr. M.F., Mitchell A., Li G., Ding S., Fitzmaurice A.M., Ryan K., et al. Toll-like receptor (TLR) 2 and TLR5, but not TLR4, are required for Helicobacter pylori-induced NF-kappa B activation and chemokine expression by epithelial cells. J Biol Chem 278 (2003) 32552-32560
3. Ohara T., Morishita T., Suzuki H., and Hibi T. Heterozygous Thr135Ala polymorphism at leucine-rich repeat (LRR) in genomic DNA of toll-like receptor 4 in patients with poorly-differentiated gastric adenocarcinomas. Int J Mol Med 18 (2006) 59-63
4. Trejo-dela O.A., Torres J., Perez-Rodriguez M., Camorlinga-Ponce M., Luna L.F., Abdo-Francis J.M., et al. TLR4 single-nucleotide polymorphisms alter mucosal cytokine and chemokine patterns in Mexican patients with Helicobacter pylori-associated gastroduodenal diseases. Clin Immunol 129 (2008) 333-340
5. Hold G.L., Rabkin C.S., Chow W.H., Smith M.G., Gammon M.D., Risch H.A., et al. A functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors. Gastroenterology 132 (2007) 905-912
6. Achyut B.R., Ghoshal U.C., Moorchung N., and Mittal B. Association of Toll-like receptor-4 (Asp299Gly and Thr399Ileu) gene polymorphisms with gastritis and precancerous lesions. Hum Immunol 68 (2007) 901-907
7. Santini D., Angeletti S., Ruzzo A., Dicuonzo G., Galluzzo S., Vincenzi B., et al. Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypes. Clin Exp Immunol 154 (2008) 360-364
8. Garza-Gonzalez E., Bosques-Padilla F.J., Mendoza-Ibarra S.I., Flores-Gutierrez J.P., Maldonado-Garza H.J., and Perez-Perez G.I. Assessment of the toll-like receptor 4 Asp299Gly, Thr399Ile and interleukin-8 -251 polymorphisms in the risk for the development of distal gastric cancer. BMC Cancer 7 (2007) 70
9. Noguchi E., Nishimura F., Fukai H., Kim J., Ichikawa K., Shibasaki M., et al. An association study of asthma and total serum immunoglobin E levels for Toll-like receptor polymorphisms in a Japanese population. Clin Exp Allergy 34 (2004) 177-183
10. Wu M.S., Cheng T.Y., Shun C.T., Lin M.T., Chen L.C., and Lin J.T. Functional polymorphisms of CD14 and toll-like receptor 4 in Taiwanese Chinese with Helicobacter pylori-related gastric malignancies. Hepatogastroenterol 53 (2006) 807-810
11. Tahara T., Arisawa T., Shibata T., Hirata I., and Nakano H. Absence of common polymorphisms of toll like receptor 4 (TLR4): Asp299Gly, Thr399Ile in patients with gastroduodenal diseases in Japan. J Clin Biochem Nutr 40 (2007) 62-65
12. Wu J., Lu Y., Ding Y.B., Ke Q., Hu Z.B., Yan Z.G., et al. Promoter polymorphisms of IL2, IL4, and risk of gastric cancer in a high-risk Chinese population. Mol Carcinog 48 (2009) 626-632
13. Lauren P. The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. an attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64 (1965) 31-49
14. Schmausser B., Andrulis M., Endrich S., Lee S.K., Josenhans C., Muller-Hermelink H.K., et al. Expression and subcellular distribution of toll-like receptors TLR4, TLR5 and TLR9 on the gastric epithelium in Helicobacter pylori infection. Clin Exp Immunol 136 (2004) 521-526
15. Takeda K., and Akira S. Toll-like receptors in innate immunity. Int Immunol 17 (2005) 1-14
16. Lawrence T. Inflammation and cancer: a failure of resolution?. Trends Pharmacol Sci 28 (2007) 162-165
17. Arbour N.C., Lorenz E., Schutte B.C., Zabner J., Kline J.N., Jones M., et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 25 (2000) 187-191
18. Ferwerda B., McCall M.B., Alonso S., Giamarellos-Bourboulis E.J., Mouktaroudi M., Izagirre N., et al. TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans. Proc Natl Acad Sci U S A 104 (2007) 16645-16650
19. Ferwerda B., McCall M.B., Verheijen K., Kullberg B.J., van der Ven A.J., Van der Meer J.W., et al. Functional consequences of toll-like receptor 4 polymorphisms. Mol Med 14 (2008) 346-352
20. Hang J., Zhou W., Zhang H., Sun B., Dai H., Su L., et al. TLR4 Asp299Gly and Thr399Ile polymorphisms are very rare in the Chinese population. J Endotoxin Res 10 (2004) 238-240
21. Lin Y.C., Chang Y.M., Yu J.M., Yen J.H., Chang J.G., and Hu C.J. Toll-like receptor 4 gene C119A but not Asp299Gly polymorphism is associated with ischemic stroke among ethnic Chinese in Taiwan. Atherosclerosis 180 (2005) 305-309
22. Agnese D.M., Calvano J.E., Hahm S.J., Coyle S.M., Corbett S.A., Calvano S.E., et al. Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. J Infect Dis 186 (2002) 1522-1525
23. Child N.J., Yang I.A., Pulletz M.C., de Courcy-Golder K., Andrews A.L., Pappachan V.J., et al. Polymorphisms in Toll-like receptor 4 and the systemic inflammatory response syndrome. Biochem Soc Trans 31 (2003) 652-653
24. Faber J., Meyer C.U., Gemmer C., Russo A., Finn A., Murdoch C., et al. Human toll-like receptor 4 mutations are associated with susceptibility to invasive meningococcal disease in infancy. Pediatr Infect Dis J 25 (2006) 80-81
25. Su B., Ceponis P.J., Lebel S., Huynh H., and Sherman P.M. Helicobacter pylori activates Toll-like receptor 4 expression in gastrointestinal epithelial cells. Infect Immun 71 (2003) 3496-3502
26. Saadat I., Higashi H., Obuse C., Umeda M., Murata-Kamiya N., Saito Y., et al. Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity. Nature 447 (2007) 330-333